These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 23472830)
1. Role of transcription factors in the pathogenesis of asthma and COPD. Caramori G; Casolari P; Adcock I Cell Commun Adhes; 2013 Feb; 20(1-2):21-40. PubMed ID: 23472830 [TBL] [Abstract][Full Text] [Related]
5. Regulation of airway inflammation and remodeling by muscarinic receptors: perspectives on anticholinergic therapy in asthma and COPD. Kistemaker LE; Oenema TA; Meurs H; Gosens R Life Sci; 2012 Nov; 91(21-22):1126-33. PubMed ID: 22406302 [TBL] [Abstract][Full Text] [Related]
6. Handle with care: targeting neutrophils in chronic obstructive pulmonary disease and severe asthma? Beeh KM; Beier J Clin Exp Allergy; 2006 Feb; 36(2):142-57. PubMed ID: 16433851 [TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies for asthma and chronic obstructive pulmonary disease. Antoniu SA Expert Opin Biol Ther; 2013 Feb; 13(2):257-68. PubMed ID: 23282002 [TBL] [Abstract][Full Text] [Related]
9. Chronic obstructive pulmonary disease: an update on nuclear signaling related to inflammation and anti-inflammatory treatment. Mroz RM; Holownia A; Chyczewska E; Braszko JJ J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():35-42. PubMed ID: 19218631 [TBL] [Abstract][Full Text] [Related]
10. TH17 cells in asthma and COPD. Alcorn JF; Crowe CR; Kolls JK Annu Rev Physiol; 2010; 72():495-516. PubMed ID: 20148686 [TBL] [Abstract][Full Text] [Related]
11. Heterogeneity in mechanisms influencing glucocorticoid sensitivity: the need for a systems biology approach to treatment of glucocorticoid-resistant inflammation. Keenan CR; Radojicic D; Li M; Radwan A; Stewart AG Pharmacol Ther; 2015 Jun; 150():81-93. PubMed ID: 25596317 [TBL] [Abstract][Full Text] [Related]
12. Small molecule inhibitors of cell signaling: novel future therapeutics for asthma and chronic obstructive pulmonary diseases. Blease K; Raymon HK Curr Opin Investig Drugs; 2003 May; 4(5):544-51. PubMed ID: 12833647 [TBL] [Abstract][Full Text] [Related]
13. Inflammation Research Association--15th international conference advances in asthma and COPD and other inflammatory diseases. Walker K IDrugs; 2008 Dec; 11(12):863-5. PubMed ID: 19051144 [No Abstract] [Full Text] [Related]
14. Emerging trends in the therapy of COPD: novel anti-inflammatory agents in clinical development. Fitzgerald MF; Fox JC Drug Discov Today; 2007 Jun; 12(11-12):479-86. PubMed ID: 17532533 [TBL] [Abstract][Full Text] [Related]
15. Epigenetic regulation of airway inflammation. Adcock IM; Tsaprouni L; Bhavsar P; Ito K Curr Opin Immunol; 2007 Dec; 19(6):694-700. PubMed ID: 17720468 [TBL] [Abstract][Full Text] [Related]
16. Regulation of inflammatory cell function by corticosteroids. Belvisi MG Proc Am Thorac Soc; 2004; 1(3):207-14. PubMed ID: 16113436 [TBL] [Abstract][Full Text] [Related]
17. The effects of cigarette smoke on airway inflammation in asthma and COPD: therapeutic implications. Tamimi A; Serdarevic D; Hanania NA Respir Med; 2012 Mar; 106(3):319-28. PubMed ID: 22196881 [TBL] [Abstract][Full Text] [Related]
18. Novel therapies for the treatment of inflammatory airway disease. Hele DJ; Belvisi MG Expert Opin Investig Drugs; 2003 Jan; 12(1):5-18. PubMed ID: 12517250 [TBL] [Abstract][Full Text] [Related]
19. Targeting immune pathways for therapy in asthma and chronic obstructive pulmonary disease. Brusselle G; Bracke K Ann Am Thorac Soc; 2014 Dec; 11 Suppl 5():S322-8. PubMed ID: 25525740 [TBL] [Abstract][Full Text] [Related]
20. Genetic and biochemical markers of obstructive lung disease in the general population. Dahl M Clin Respir J; 2009 Apr; 3(2):121-2. PubMed ID: 20298391 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]